Literature DB >> 8868257

Neural regulation of corticotropin releasing hormone (CRH) and CRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat.

A Kiss1, M Palkovits, G Aguilera.   

Abstract

The role of afferent innervation to the hypothalamic paraventricular nucleus (PVN) on CRH mRNA and CRH receptor mRNA levels was studied in control and stressed rats. Groups of rats were subjected to unilateral transection of the stria terminalis (ST), the medial forebrain bundle at the rostral hypothalamic level (RMFB), or the lower brainstem through the medulla oblongata between the obex and the locus coeruleus (CBs). Twelve days after surgery, each group of rats was further divided into controls (basal conditions) and stressed (1 h immobilization), before collecting brains for mRNA analysis by in situ hybridization histochemistry. While ST and RMFB cuts had no effect on basal CRH mRNA levels in the PVN, CBs cut decreased CRH mRNA in the PVN ipsilaterally to the knife cut but it was without effect on the contralateral side (-40% and -37% vs contralateral and sham-operated, respectively, P < 0.01). Acute stress (rats were killed 3 h after immobilization) increased CRH mRNA levels by about 30% bilaterally, an effect which was unchanged by any of the three hemisections. Under basal conditions, CRH receptor mRNA levels in the PVN were indistinguishable from the surrounding areas in sham-operated controls, ST and RMFB operated rats. However, brainstem hemisection resulted in clear expression of CRH receptor mRNA in areas consistent with the dorsal, medial-ventral and lateral parvicellular subdivisions of the PVN, ipsilateral to the transection. CRH neurons in these subdivisions project to the lower brainstem and the spinal cord. Expression of CRH receptor mRNA in the medial-dorsal and anterior parvicellular divisions (CRH neurons with median eminence projections) was not affected by CBs cut. In these subdivisions, immobilization stress markedly increased CRH receptor mRNA levels but it did not influence CBs cut-induced CRH receptor expression. ST and RMFB hemisections were without effect on PVN CRH receptor mRNA levels under basal or stress conditions. Oxytocin (OT) and vasopressin (VP) mRNA levels in the magnocellular subdivision of the PVN were unchanged after immobilization, or following ST, RMFB or CBs cuts, whereas OT mRNA in the medial-ventral and caudal parvicellular subdivisions was decreased by 52% after CBs cut. The data demonstrate that: 1) basal CRH mRNA levels in the PVN are under tonic stimulatory influence of the lower brainstem (and/or spinal cord) afferents; 2) CRH receptor mRNA expression in PVN subdivisions (pituitary vs lower brainstem/spinal cord projecting neurons) is under different control mechanisms, and 3) immobilization-induced changes in CRH mRNA and CRH receptor mRNA levels are mediated either by neural inputs from brain areas other than those investigated here, or by humoral factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8868257     DOI: 10.1111/j.1365-2826.1996.tb00830.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  11 in total

1.  Neural Regulation of the Stress Response: The Many Faces of Feedback.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Cell Mol Neurobiol       Date:  2012-02-01       Impact factor: 5.046

2.  Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

Authors:  K H Skelton; C B Nemeroff; D L Knight; M J Owens
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

3.  A secretagogin locus of the mammalian hypothalamus controls stress hormone release.

Authors:  Roman A Romanov; Alán Alpár; Ming-Dong Zhang; Amit Zeisel; André Calas; Marc Landry; Matthew Fuszard; Sally L Shirran; Robert Schnell; Árpád Dobolyi; Márk Oláh; Lauren Spence; Jan Mulder; Henrik Martens; Miklós Palkovits; Mathias Uhlen; Harald H Sitte; Catherine H Botting; Ludwig Wagner; Sten Linnarsson; Tomas Hökfelt; Tibor Harkany
Journal:  EMBO J       Date:  2014-11-27       Impact factor: 11.598

4.  Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress.

Authors:  Ines Armando; Simona Volpi; Greti Aguilera; Juan M Saavedra
Journal:  Brain Res       Date:  2007-01-19       Impact factor: 3.252

5.  Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats.

Authors:  Paula J Brunton; Simone L Meddle; Shuaike Ma; Tomasz Ochedalski; Alison J Douglas; John A Russell
Journal:  J Neurosci       Date:  2005-05-25       Impact factor: 6.167

6.  Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.

Authors:  Z Merali; J McIntosh; P Kent; D Michaud; H Anisman
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

7.  ComparativeStudyofCRHMicroinjections Into PVN and CeA Nuclei on Food Intake, Ghrelin, Leptin, and Glucose Levels in Acute Stressed Rats.

Authors:  Maryam Radahmadi; Mina Sadat Izadi; Atefeh Rayatpour; Maedeh Ghasemi
Journal:  Basic Clin Neurosci       Date:  2021-01-01

8.  Sciatic nerve injury rebalances the hypothalamic-pituitary-adrenal axis in rats with persistent changes to their social behaviours.

Authors:  M Karmina Sosa; Damien C Boorman; Kevin A Keay
Journal:  J Neuroendocrinol       Date:  2022-04-29       Impact factor: 3.870

9.  PVN pathways controlling energy homeostasis.

Authors:  Jennifer W Hill
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: potential implications for human stress response and immune/inflammatory reaction.

Authors:  N C Vamvakopoulos; T O Sioutopoulou; Z Mamuris; P Marcoulatos; P C Avgerinos
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.